Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214.
View in:
PubMed
subject areas
African Americans
African Americans
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Chi-Square Distribution
Chi-Square Distribution
Drug Combinations
Drug Combinations
Drug Utilization Review
Drug Utilization Review
Female
Female
Guideline Adherence
Guideline Adherence
Healthcare Disparities
Healthcare Disparities
Heart Failure
Heart Failure
Humans
Humans
Hydralazine
Hydralazine
Isosorbide Dinitrate
Isosorbide Dinitrate
Logistic Models
Logistic Models
Male
Male
Middle Aged
Middle Aged
Multivariate Analysis
Multivariate Analysis
Practice Guidelines as Topic
Practice Guidelines as Topic
Practice Patterns, Physicians'
Practice Patterns, Physicians'
Prospective Studies
Prospective Studies
Registries
Registries
Stroke Volume
Stroke Volume
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
United States
United States
Vasodilator Agents
Vasodilator Agents
Ventricular Function, Left
Ventricular Function, Left
authors with profiles
Stavros Stavrakis
Udho Thadani